News

September 5, 2024 | Duke University School of Medicine

Debra Silver Receives Prestigious Javits Award for Brain Development Research

August 21, 2024 | Duke Today

Duke's Quantum Leap in AI

July 8, 2024 | Duke University School of Medicine

Clare Smith Named 2024 Pew Scholar

Clare Smith, PhD, assistant professor of molecular genetics and microbiology, has been named a Pew Scholar in the Biomedical Sciences. This award provides four years of funding to young investigators to explore some of the most pressing questions in human health and medicine. Smith is one of 22…

July 8, 2024 | Pratt School of Engineering

Emma Chory Awarded Hypothesis Fund Seed Grant

June 21, 2024 | Pratt School of Engineering

Lab-Grown Muscles Reveal Mysteries of Rare Muscle Diseases

Biomedical engineers at Duke University have developed a new technique to better understand and test treatments for a group of extremely rare muscle disorders called dysferlinopathy or limb girdle muscular dystrophies 2B.

May 20, 2024 | Pratt School of Engineering

Analyzing the Ethics Behind Biomedical Engineering

March 28, 2024 | Duke University School of Medicine

The Power and Promise of RNA

March 20, 2024 | Duke University School of Medicine

Human Avatars Help Make Gene Therapy More Effective

March 20, 2024 | Duke Today

Simon Gregory awarded Distinguished Professorship for 2024

February 20, 2024 | Pratt School of Engineering

Harnessing Skin Cancer Genes to Heal Hearts

January 30, 2024 | Department of Molecular Genetics & Microbiology

Dr. Adrianna San Roman Joins MGM Faculty

January 22, 2024

Gersbach part of panel discussion at Global Healthspan Summit

CAGT Director Charlie Gersbach was part of a panel discussion, "Growing a Healthier Future Together," at the Global Healthspan Summit. 

Watch the discussion on YouTube

January 9, 2024 | Duke School of Medicine

Shah Named Associate Dean for Translational Research

In this role, Shah will serve in an expanded capacity from her previous role as associate dean of genomics.

December 11, 2023 | Genetic Engineering & Biotechnology News

Rhapsody in B: Tune Therapeutics Presents Data for Hepatitis B Epigenetic Silencer

Emerging from stealth in 2021, Tune Therapeutics is one of the leaders in the rapidly growing arena of epigenome editing. The scientific co-founders are Charles Gersbach, PhD, and Fyodor Urnov, PhD. GEN Edge recently conducted an exclusive interview with Urnov, during which he spoke at length…

November 17, 2023 | Duke Research Blog

Gersbach among those on Clarivate's Most Highly Cited Scientists for 2023

Gerbach is one of the most highly cited authors in Biology & Biochemistry